WealthPlan Investment Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,326
Closed -$38.8K 410
2023
Q1
$38.8K Buy
+3,326
New +$42.4K 0.01% 266

Other funds holding HCAT

WealthPlan Investment Management's HCAT Position: Q2 2023 in Review

WealthPlan Investment Management sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 3,326 shares — an estimated $38.8K sold.

WealthPlan Investment Management first reported a position in HCAT in Q1 2023 and held it in 1 quarter. The position peaked at $38.8K in Q1 2023. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

  • WealthPlan Investment Management reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
  • WealthPlan Investment Management sold 3,326 Health Catalyst shares in Q2 2023, an estimated $38.8K.
  • WealthPlan Investment Management first reported a position in Health Catalyst in Q1 2023 and held it in 1 quarter.
  • WealthPlan Investment Management's Health Catalyst position peaked at $38.8K in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on WealthPlan Investment Management's 13F filing for Q2 2023, filed 25 Jul 2023.